首页> 外国专利> Inhibitor of human myeloid leukemia on base of bis(2-hydroxy-8-phenyl-tricyclo/7.3.1.0.2,7/-tridecane-13-on-thiosemicarbazonato)

Inhibitor of human myeloid leukemia on base of bis(2-hydroxy-8-phenyl-tricyclo/7.3.1.0.2,7/-tridecane-13-on-thiosemicarbazonato)

机译:基于双(2-羟基-8-苯基-三环/7.3.1.0.2,7/-十三烷-13-硫代半碳氮杂)的人类髓样白血病抑制剂

摘要

The invention relates to chemistry, namely to the synthesis of a coordinative compound from the class of thiosemicarbazonates of transition metals and can be applied in medicine for prophylaxis and treatment of myeloid leukemia. Summary of the invention consists in that as inhibitor of human myeloid leukemia is proposed bis(2-hydroxy-8-phenyl-tricyclo/7.3.1.0.2,7/-tridecane-13-on-thiosemicarbazonato)copper of formula:
机译:本发明涉及化学,即涉及由过渡金属的硫代半氨基甲酸酯类的配位化合物的合成,可用于预防和治疗骨髓性白血病的药物。发明内容在于,作为人髓样白血病的抑制剂,提出了具有以下结构的双(2-羟基-8-苯基-三环/7.3.1.0.2,7/-十三烷-13-硫代半碳氮杂)铜。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号